Images (1)

Exanthema, acneiformesR21.x

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

acne medicamentosa

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Predominantly drug-induced skin symptoms with acne-like efflorescences, but without comedones. S.a. Acne medicamentosa.

EtiopathogenesisThis section has been translated automatically.

Possible triggers are above all: glucocorticoids ( steroid acne), also ACTH, diphenylhydantoin, quinine, isoniazid. Furthermore: halogen-containing drugs like iodine compounds, bromine compounds. Furthermore: lithium, phenobarbiturates, disulfiram, thyrostatic drugs (thiourea, thiouracil). Furthermore: vitaminB1, B6, B12, tyrosine kinase inhibitors like cetuximab (belongs together with gifitinib and erlotinib to a group of cancer therapeutics whose common feature is the blockade of the epidermal growth factor receptor[ EGF-receptor]; acne-like skin changes occur in > 80% of cases, about 2-6 weeks after the start of therapy).

LocalizationThis section has been translated automatically.

Especially in the seborrhoeic zones and the upper arms.

TherapyThis section has been translated automatically.

Stop the medication. S.a.u. Acne medicamentosa.

LiteratureThis section has been translated automatically.

  1. Braun-Falco M et al (2006) Follicular drug reaction to cetuximab. dermatologist 57: 701-704

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer